UPDATE: Oppenheimer Upgrades Ariad Pharmaceuticals on Revised Outlook Following Recent Updates
UPDATE: Oppenheimer Raised PT on Verastem Following Analyst Day
UPDATE: Oppenheimer Initiates Kamada at Outperform on Pioneering Inhaled Delivery with AAT Treatment
UPDATE: Oppenheimer Initiates Coverage on Neurocrine Biosciences on Potential Elagolix Success